Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2000
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012073A1 Use of 5ht-6 antagonists
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO2000012043A1 Improved stability for injection solutions
03/09/2000WO1999065518A3 Lt and ct in parenteral immunization methods against helicobacter infection
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999062893A3 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999059524A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
03/09/2000WO1999058123A3 Novel fatty acid analogues for the treatment of primary and secondary restenosis
03/09/2000WO1999051215A3 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
03/09/2000WO1999043791A3 Diisopropyl fluorophosphatase and the utilization and production thereof
03/09/2000WO1999020260A3 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
03/09/2000CA2342350A1 Promoters of neural regeneration
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342245A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000CA2342230A1 2-oxo-2h-quinoline derivatives
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341612A1 Indazole derivatives with 5-ht2 receptor activity
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341499A1 Pharmaceutical compositions comprising factor xiiia
03/09/2000CA2341488A1 Therapies for treating pulmonary diseases
03/09/2000CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341409A1 Novel angiogenesis inhibitors
03/09/2000CA2341386A1 Collections of compounds
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
03/08/2000EP0983992A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983991A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983765A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance
03/08/2000EP0983726A1 Amino acid-trehalose composition
03/08/2000EP0983380A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
03/08/2000EP0983360A1 Smad7 and uses thereof
03/08/2000EP0983359A1 DETECTION OF LOSS OF THE WILD-TYPE $i(hu)BUB1 GENE
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983304A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
03/08/2000EP0983300A1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
03/08/2000EP0983295A2 4-aza-steroids substituted in one or more of positions 7, 11 and 15 or with an unsaturated 14(15)-double bond as inhibitors of testosterone-5-alpha-reductase
03/08/2000EP0983294A1 B-ring estratriene diol sulphates
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds
03/08/2000EP0983268A1 Amidine derivatives as inhibitors of nitric oxide synthase
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983266A1 Compounds
03/08/2000EP0983265A1 Endothelin receptor antagonists
03/08/2000EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983249A1 Processes and intermediates for preparing substituted indazole derivatives
03/08/2000EP0983248A1 Analogs of duocarmycin and cc-1065
03/08/2000EP0983245A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000EP0983243A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
03/08/2000EP0983235A2 Leukotriene b 4? derivatives, in particular oximo-ltb 4? antagonists
03/08/2000EP0983229A1 Metalloproteinase inhibitors
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983091A1 Obesity protein formulations
03/08/2000EP0983082A1 Novel administration of thrombopoietin
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
03/08/2000EP0983076A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
03/08/2000EP0983075A1 A method to increase the survival of transplanted cells
03/08/2000EP0983068A1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
03/08/2000EP0983066A1 Pharmaceutical composition comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000EP0983062A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
03/08/2000EP0982991A1 Beta lactams as antiproliferative agents
03/08/2000EP0871655B1 Pcna binding substance
03/08/2000EP0820275A4 Cosmetic melanins
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
03/08/2000CN1246860A 3-aryl substituted pyrazolo [4,3-d] pyrimidine derivatives, corticotropin-releasing factor receptor (CRT1) specific ligands
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/08/2000CN1246847A Nitrogen containing heteroaromatics as factor Xa inhibitors
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246793A Method and compositions for treating allergic asthma and other diseases using descartoethoxyloratadine
03/08/2000CN1246345A Medical liquor for nourishing kidney
03/08/2000CN1050132C Ginkgotide derivatives
03/08/2000CN1050129C Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
03/08/2000CN1050128C 5-acrylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/08/2000CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them
1 ... 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 ... 1564